top of page

WORLDWIDE, 26,000 PEOPLE DIE FROM CANCER EACH DAY

By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. 

Earlier diagnosis of cancer results in significantly higher survival rates compared to late-stage diagnosis, increasing the availability of treatment options, and improving chances of recovery and a better quality of life.
cancer_MG_2484.jpg
Chroma-Background.jpg

DXCOVER BRAIN CANCER

With the Dxcover Brain Cancer Liquid Biopsy, doctors will finally have a fast, inexpensive, and easy way to accurately test for brain cancer.

90%

OF PATIENTS SURVIVE WHEN CANCER IS FOUND EARLY. EARLY DIAGNOSIS BEATS CANCER. 

Reference - CRUK Statistics impact of early diagnosis

THE DXCOVER LIQUID BIOPSY IS A BLOOD TEST FOR EARLY DETECTION OF CANCER.

The Dxcover Platform and patented Drop Dry Detect method enables rapid development of a range of tests.

Our Dxcover Cancer project is developing liquid biopsies for the most common cancers.

​

Our Dxcover Brain Cancer liquid biopsy has successfully completed two clinical studies.

bottom of page